Monimate Tablet (Moniflumet)

Adult dose

Adults: The initial dose is 350 milligrams of moflumate twice daily. Depending on the patient, the dose may be increased to a maximum of 700 milligrams twice daily. It is preferable to start this medicine at a low dose and increase it to the effective dose. Adjust the dose as appropriate according to age and symptoms.

This medication may pose a risk of gastrointestinal bleeding, especially for individuals who consume more than three alcoholic beverages daily on a regular basis; therefore, it is important to consult a physician or pharmacist. This medication may increase the risk of cardiovascular diseases and can lead to serious issues such as myocardial infarction or stroke, hence caution is advised if there is a history of cardiovascular disease or known risk factors. This medication can cause serious gastrointestinal problems such as gastrointestinal bleeding, ulcers, and perforation, and the risk may be higher in the elderly or with prolonged use, necessitating careful monitoring for gastrointestinal symptoms. Allergic reactions, especially severe hypersensitivity reactions like anaphylaxis, may occur; caution is needed even in patients who have never taken non-steroidal anti-inflammatory drugs (NSAIDs). While it has anti-inflammatory and pain-relief effects, it may delay the diagnosis of infectious complications, so it should be cautiously used when infection is suspected. It should not be administered to certain patients such as those with peptic ulcers, gastrointestinal bleeding, severe liver, kidney, or heart disease, pregnant or nursing women, and children, as well as individuals with lactose intolerance. Those with blood disorders, tendencies for bleeding, reduced liver or kidney function, hypertension, heart failure, autoimmune diseases, asthma, ulcerative colitis, Crohn's disease, and the elderly should use this medication with particular caution. While taking this medication, various side effects such as nausea, vomiting, abdominal pain, diarrhea, skin rash, liver function abnormalities, kidney issues, and psychiatric symptoms may occur, and any unusual symptoms should be discussed with a physician immediately. This medication should be used at the lowest effective dose for the shortest duration, and regular blood tests and liver and kidney function tests are recommended for those on long-term therapy. There may be an increased risk of side effects when taking this medication in conjunction with other anti-inflammatory drugs or specific medications, so patients should inform their physician of all concurrent medications. During pregnancy, it may pose risks to the fetus, hence caution is advised in women who may become pregnant, and the elderly should initiate treatment at a lower dose, closely monitoring for side effects. This medication should be taken with sufficient water to prevent it from lingering in the esophagus and should not be taken on an empty stomach or just before bedtime. In case of an overdose, appropriate emergency measures such as inducing vomiting, gastric lavage, or administering activated charcoal are necessary; symptoms of renal failure or respiratory depression may occur, requiring immediate medical attention. Storage should be in a tightly closed container away from air and moisture, and at a temperature between 1 degree and 30 degrees Celsius, to preserve the effectiveness of the medication.

• Shock symptoms
• nausea
• vomiting
• abdominal pain
• heartburn
• diarrhea
• bleeding
• esophageal ulcer
• loss of appetite
• dyspepsia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage can maintain the drug's efficacy over time.

Appearance

White to light yellow oval-shaped tablet

Package unit

30 tablets/bottle, 100 tablets/bottle